| | Univariate | Multivariate | HR (95% CI) | value | A | B | HR (95% CI) | value | HR (95% CI) | value |
| Age (years) | 1.08 (1.06, 1.10) | <0.001 | 1.07 (1.05, 1.09) | <0.001 | 1.06 (1.04, 1.07) | <0.001 | Male (%) | 0.85 (0.63, 1.17) | 0.320 | | | | | Stroke (%) | 1.90 (1.35, 2.68) | <0.001 | | | 1.47 (1.08, 1.98) | 0.014 | Heart rate (bpm) | 1.02 (1.01, 1.03) | <0.001 | 1.02 (1.01, 1.03) | 0.001 | 1.01 (1.00, 1.02) | 0.030 | hsCRP (mg/L) | 1.02 (1.00, 1.05) | 0.031 | | | | | HbA1C (%) | 1.15 (1.04, 1.28) | 0.008 | | | 1.19 (1.08, 1.30) | <0.001 | LVEF ≥ 50% | Ref | | Ref | | Ref | | 40% ≤ LVEF < 50% | 2.93 (1.59, 5.41) | 0.001 | 2.23 (1.19, 4.16) | 0.012 | 1.89 (1.07, 3.34) | 0.029 | LVEF < 40% | 1.30 (0.32, 5.24) | 0.714 | 1.19 (0.29, 4.87) | 0.814 | 0.87 (0.21, 3.54) | 0.845 | LM (%) | 2.47 (1.70, 3.61) | <0.001 | 1.62 (1.09, 2.39) | 0.016 | 1.52 (1.08, 2.16) | 0.017 | Multivessels (%) | 3.78 (2.05, 6.97) | <0.001 | 260 (1.39, 4.85) | 0.003 | 2.22 (1.34, 3.69) | 0.002 | CTO (%) | 2.42 (1.64, 3.58) | <0.001 | 1.71 (1.13, 2.57) | 0.010 | | | β-Blockers at discharge (%) | 1.40 (1.03, 1.91) | 0.033 | | | | |
|
|
A, present all-cause death/HF; B, present all-cause death/HF/nonfatal MI. MI, myocardial infarction; HbAIC, glycosylated hemoglobin; hsCRP, hypersensitivity C-reactive protein; LVEF, left ventricular ejection fraction; LM, left main trunk; CTO, chronic total occlusions.
|